IBDEI0A7 ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12930,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12930,1,3,0)
 ;;=3^Chronic Sinusitis,Unspec
 ;;^UTILITY(U,$J,358.3,12930,1,4,0)
 ;;=4^J32.9
 ;;^UTILITY(U,$J,358.3,12930,2)
 ;;=^5008207
 ;;^UTILITY(U,$J,358.3,12931,0)
 ;;=J30.9^^43^615^11
 ;;^UTILITY(U,$J,358.3,12931,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12931,1,3,0)
 ;;=3^Allergic Rhinitis,Unspec
 ;;^UTILITY(U,$J,358.3,12931,1,4,0)
 ;;=4^J30.9
 ;;^UTILITY(U,$J,358.3,12931,2)
 ;;=^5008205
 ;;^UTILITY(U,$J,358.3,12932,0)
 ;;=J30.0^^43^615^24
 ;;^UTILITY(U,$J,358.3,12932,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12932,1,3,0)
 ;;=3^Vasomotor Rhinitis
 ;;^UTILITY(U,$J,358.3,12932,1,4,0)
 ;;=4^J30.0
 ;;^UTILITY(U,$J,358.3,12932,2)
 ;;=^5008201
 ;;^UTILITY(U,$J,358.3,12933,0)
 ;;=K05.00^^43^615^2
 ;;^UTILITY(U,$J,358.3,12933,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12933,1,3,0)
 ;;=3^Acute Gingivitis,Plaque Induced
 ;;^UTILITY(U,$J,358.3,12933,1,4,0)
 ;;=4^K05.00
 ;;^UTILITY(U,$J,358.3,12933,2)
 ;;=^334192
 ;;^UTILITY(U,$J,358.3,12934,0)
 ;;=R04.0^^43^615^17
 ;;^UTILITY(U,$J,358.3,12934,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12934,1,3,0)
 ;;=3^Epistaxis
 ;;^UTILITY(U,$J,358.3,12934,1,4,0)
 ;;=4^R04.0
 ;;^UTILITY(U,$J,358.3,12934,2)
 ;;=^5019173
 ;;^UTILITY(U,$J,358.3,12935,0)
 ;;=R09.82^^43^615^21
 ;;^UTILITY(U,$J,358.3,12935,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12935,1,3,0)
 ;;=3^Postnasal Drip
 ;;^UTILITY(U,$J,358.3,12935,1,4,0)
 ;;=4^R09.82
 ;;^UTILITY(U,$J,358.3,12935,2)
 ;;=^97058
 ;;^UTILITY(U,$J,358.3,12936,0)
 ;;=K12.30^^43^615^20
 ;;^UTILITY(U,$J,358.3,12936,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12936,1,3,0)
 ;;=3^Oral Mucositis,Unspec
 ;;^UTILITY(U,$J,358.3,12936,1,4,0)
 ;;=4^K12.30
 ;;^UTILITY(U,$J,358.3,12936,2)
 ;;=^5008486
 ;;^UTILITY(U,$J,358.3,12937,0)
 ;;=J30.1^^43^615^10
 ;;^UTILITY(U,$J,358.3,12937,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12937,1,3,0)
 ;;=3^Allergic Rhinitis d/t Pollen
 ;;^UTILITY(U,$J,358.3,12937,1,4,0)
 ;;=4^J30.1
 ;;^UTILITY(U,$J,358.3,12937,2)
 ;;=^269906
 ;;^UTILITY(U,$J,358.3,12938,0)
 ;;=R09.81^^43^615^18
 ;;^UTILITY(U,$J,358.3,12938,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12938,1,3,0)
 ;;=3^Nasal Congestion
 ;;^UTILITY(U,$J,358.3,12938,1,4,0)
 ;;=4^R09.81
 ;;^UTILITY(U,$J,358.3,12938,2)
 ;;=^5019203
 ;;^UTILITY(U,$J,358.3,12939,0)
 ;;=I69.928^^43^615^22
 ;;^UTILITY(U,$J,358.3,12939,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12939,1,3,0)
 ;;=3^Speech/Lang Deficit Following Cerebvasc Disease
 ;;^UTILITY(U,$J,358.3,12939,1,4,0)
 ;;=4^I69.928
 ;;^UTILITY(U,$J,358.3,12939,2)
 ;;=^5007557
 ;;^UTILITY(U,$J,358.3,12940,0)
 ;;=I69.328^^43^615^23
 ;;^UTILITY(U,$J,358.3,12940,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12940,1,3,0)
 ;;=3^Speech/Lang Deficit Following Cerebvasc Infarc
 ;;^UTILITY(U,$J,358.3,12940,1,4,0)
 ;;=4^I69.328
 ;;^UTILITY(U,$J,358.3,12940,2)
 ;;=^5007495
 ;;^UTILITY(U,$J,358.3,12941,0)
 ;;=E04.0^^43^616^39
 ;;^UTILITY(U,$J,358.3,12941,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12941,1,3,0)
 ;;=3^Nontoxic Diffuse Goiter
 ;;^UTILITY(U,$J,358.3,12941,1,4,0)
 ;;=4^E04.0
 ;;^UTILITY(U,$J,358.3,12941,2)
 ;;=^5002477
 ;;^UTILITY(U,$J,358.3,12942,0)
 ;;=E04.1^^43^616^41
 ;;^UTILITY(U,$J,358.3,12942,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12942,1,3,0)
 ;;=3^Nontoxic Single Thyroid Nodule
 ;;^UTILITY(U,$J,358.3,12942,1,4,0)
 ;;=4^E04.1
 ;;^UTILITY(U,$J,358.3,12942,2)
 ;;=^5002478
 ;;^UTILITY(U,$J,358.3,12943,0)
 ;;=E04.2^^43^616^40
 ;;^UTILITY(U,$J,358.3,12943,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12943,1,3,0)
 ;;=3^Nontoxic Multinodular Goiter
 ;;^UTILITY(U,$J,358.3,12943,1,4,0)
 ;;=4^E04.2
 ;;^UTILITY(U,$J,358.3,12943,2)
 ;;=^267790
 ;;^UTILITY(U,$J,358.3,12944,0)
 ;;=E01.1^^43^616^36
 ;;^UTILITY(U,$J,358.3,12944,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12944,1,3,0)
 ;;=3^Iodine-Deficiency Related Multinodular (Endemic) Goiter
 ;;^UTILITY(U,$J,358.3,12944,1,4,0)
 ;;=4^E01.1
 ;;^UTILITY(U,$J,358.3,12944,2)
 ;;=^5002465
 ;;^UTILITY(U,$J,358.3,12945,0)
 ;;=E05.00^^43^616^56
 ;;^UTILITY(U,$J,358.3,12945,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12945,1,3,0)
 ;;=3^Thyrotoxicosis w/ Diffuse Goiter w/o Thyrotoxic Crisis
 ;;^UTILITY(U,$J,358.3,12945,1,4,0)
 ;;=4^E05.00
 ;;^UTILITY(U,$J,358.3,12945,2)
 ;;=^5002481
 ;;^UTILITY(U,$J,358.3,12946,0)
 ;;=E05.01^^43^616^55
 ;;^UTILITY(U,$J,358.3,12946,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12946,1,3,0)
 ;;=3^Thyrotoxicosis w/ Diffuse Goiter w/ Thyrotoxic Crisis/Storm
 ;;^UTILITY(U,$J,358.3,12946,1,4,0)
 ;;=4^E05.01
 ;;^UTILITY(U,$J,358.3,12946,2)
 ;;=^5002482
 ;;^UTILITY(U,$J,358.3,12947,0)
 ;;=E05.90^^43^616^58
 ;;^UTILITY(U,$J,358.3,12947,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12947,1,3,0)
 ;;=3^Thyrotoxicosis,Unspec w/o Thyrotoxic Crisis/Storm
 ;;^UTILITY(U,$J,358.3,12947,1,4,0)
 ;;=4^E05.90
 ;;^UTILITY(U,$J,358.3,12947,2)
 ;;=^5002492
 ;;^UTILITY(U,$J,358.3,12948,0)
 ;;=E05.91^^43^616^57
 ;;^UTILITY(U,$J,358.3,12948,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12948,1,3,0)
 ;;=3^Thyrotoxicosis,Unspec w/ Thyrotoxic Crisis/Storm
 ;;^UTILITY(U,$J,358.3,12948,1,4,0)
 ;;=4^E05.91
 ;;^UTILITY(U,$J,358.3,12948,2)
 ;;=^5002493
 ;;^UTILITY(U,$J,358.3,12949,0)
 ;;=E89.0^^43^616^50
 ;;^UTILITY(U,$J,358.3,12949,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12949,1,3,0)
 ;;=3^Postprocedural Hypothyroidism
 ;;^UTILITY(U,$J,358.3,12949,1,4,0)
 ;;=4^E89.0
 ;;^UTILITY(U,$J,358.3,12949,2)
 ;;=^5003035
 ;;^UTILITY(U,$J,358.3,12950,0)
 ;;=E03.2^^43^616^32
 ;;^UTILITY(U,$J,358.3,12950,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12950,1,3,0)
 ;;=3^Hypothyroidism d/t Meds/Oth Exogenous Substances
 ;;^UTILITY(U,$J,358.3,12950,1,4,0)
 ;;=4^E03.2
 ;;^UTILITY(U,$J,358.3,12950,2)
 ;;=^5002471
 ;;^UTILITY(U,$J,358.3,12951,0)
 ;;=E03.9^^43^616^33
 ;;^UTILITY(U,$J,358.3,12951,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12951,1,3,0)
 ;;=3^Hypothyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,12951,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,12951,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,12952,0)
 ;;=E06.0^^43^616^53
 ;;^UTILITY(U,$J,358.3,12952,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12952,1,3,0)
 ;;=3^Thyroiditis,Acute
 ;;^UTILITY(U,$J,358.3,12952,1,4,0)
 ;;=4^E06.0
 ;;^UTILITY(U,$J,358.3,12952,2)
 ;;=^2692
 ;;^UTILITY(U,$J,358.3,12953,0)
 ;;=E06.1^^43^616^54
 ;;^UTILITY(U,$J,358.3,12953,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12953,1,3,0)
 ;;=3^Thyroiditis,Subacute
 ;;^UTILITY(U,$J,358.3,12953,1,4,0)
 ;;=4^E06.1
 ;;^UTILITY(U,$J,358.3,12953,2)
 ;;=^119376
 ;;^UTILITY(U,$J,358.3,12954,0)
 ;;=C73.^^43^616^37
 ;;^UTILITY(U,$J,358.3,12954,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12954,1,3,0)
 ;;=3^Malig Neop of Thyroid Gland
 ;;^UTILITY(U,$J,358.3,12954,1,4,0)
 ;;=4^C73.
 ;;^UTILITY(U,$J,358.3,12954,2)
 ;;=^267296
 ;;^UTILITY(U,$J,358.3,12955,0)
 ;;=E10.21^^43^616^8
 ;;^UTILITY(U,$J,358.3,12955,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12955,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,12955,1,4,0)
 ;;=4^E10.21
 ;;^UTILITY(U,$J,358.3,12955,2)
 ;;=^5002589
 ;;^UTILITY(U,$J,358.3,12956,0)
 ;;=E10.9^^43^616^12
 ;;^UTILITY(U,$J,358.3,12956,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12956,1,3,0)
 ;;=3^DM Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,12956,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,12956,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,12957,0)
 ;;=E11.21^^43^616^17
 ;;^UTILITY(U,$J,358.3,12957,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12957,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,12957,1,4,0)
 ;;=4^E11.21
 ;;^UTILITY(U,$J,358.3,12957,2)
 ;;=^5002629
 ;;^UTILITY(U,$J,358.3,12958,0)
 ;;=E11.39^^43^616^18
 ;;^UTILITY(U,$J,358.3,12958,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12958,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Ophthalmic Complication NEC
 ;;^UTILITY(U,$J,358.3,12958,1,4,0)
 ;;=4^E11.39
 ;;^UTILITY(U,$J,358.3,12958,2)
 ;;=^5002643
 ;;^UTILITY(U,$J,358.3,12959,0)
 ;;=E11.43^^43^616^15
 ;;^UTILITY(U,$J,358.3,12959,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12959,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Autonomic Neuropathy
 ;;^UTILITY(U,$J,358.3,12959,1,4,0)
 ;;=4^E11.43
 ;;^UTILITY(U,$J,358.3,12959,2)
 ;;=^5002647
 ;;^UTILITY(U,$J,358.3,12960,0)
 ;;=E11.59^^43^616^13
 ;;^UTILITY(U,$J,358.3,12960,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12960,1,3,0)
 ;;=3^DM Type 2 w/ Circulatory Complications NEC
 ;;^UTILITY(U,$J,358.3,12960,1,4,0)
 ;;=4^E11.59
 ;;^UTILITY(U,$J,358.3,12960,2)
 ;;=^5002652
 ;;^UTILITY(U,$J,358.3,12961,0)
 ;;=E11.618^^43^616^14
 ;;^UTILITY(U,$J,358.3,12961,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12961,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Arthropathy NEC
 ;;^UTILITY(U,$J,358.3,12961,1,4,0)
 ;;=4^E11.618
 ;;^UTILITY(U,$J,358.3,12961,2)
 ;;=^5002654
 ;;^UTILITY(U,$J,358.3,12962,0)
 ;;=E11.621^^43^616^16
 ;;^UTILITY(U,$J,358.3,12962,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12962,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Foot Ulcer
 ;;^UTILITY(U,$J,358.3,12962,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,12962,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,12963,0)
 ;;=E11.622^^43^616^20
 ;;^UTILITY(U,$J,358.3,12963,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12963,1,3,0)
 ;;=3^DM Type 2 w/ Skin Ulcer NEC
 ;;^UTILITY(U,$J,358.3,12963,1,4,0)
 ;;=4^E11.622
 ;;^UTILITY(U,$J,358.3,12963,2)
 ;;=^5002657
 ;;^UTILITY(U,$J,358.3,12964,0)
 ;;=E11.65^^43^616^19
 ;;^UTILITY(U,$J,358.3,12964,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12964,1,3,0)
 ;;=3^DM Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,12964,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,12964,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,12965,0)
 ;;=E11.9^^43^616^21
 ;;^UTILITY(U,$J,358.3,12965,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12965,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,12965,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,12965,2)
 ;;=^5002666
